Africa's new affordable HIV treatment deal under threat from US budget cuts
A drug widely available in the west is finally affordable for African nations, but Donald Trump's budget cuts threaten that progress
A “best in class” HIV/Aids treatment drug will now be be more affordable to African nations, but proposed budget cuts by the US could make ending the epidemic difficult.
A new pricing partnership has been struck between the UN, African nation governments such as South Africa and Kenya, the pharmaceutical industry, and the US President’s Emergency Plan for Aids Relief (PEPFAR) to drastically reduce the price of a crucial HIV/Aids treatment drug.
The cost for treatment has now been set at around $75 per person per year in over 90 low to middle-income countries. The treatment cost was previously upwards of a $1,000. READ MORE